Home/Filings/4/0001144204-18-008232
4//SEC Filing

Miller Larry Lee 4

Accession 0001144204-18-008232

CIK 0001069899other

Filed

Feb 12, 7:00 PM ET

Accepted

Feb 13, 9:14 PM ET

Size

26.5 KB

Accession

0001144204-18-008232

Insider Transaction Report

Form 4
Period: 2018-02-09
Miller Larry Lee
Chief Operating Officer
Transactions
  • Exercise/Conversion

    Class A Common Stock

    2018-02-09$11.83/sh+8,582$101,5258,582 total
  • Sale

    Class A Common Stock

    2018-02-09$35.36/sh8,582$303,4600 total
  • Exercise/Conversion

    Class A Common Stock

    2018-02-12$11.83/sh+500$5,915500 total
  • Sale

    Class A Common Stock

    2018-02-12$36.22/sh500$18,1100 total
  • Exercise/Conversion

    Class A Common Stock

    2018-02-09$11.83/sh+5,600$66,2485,600 total
  • Sale

    Class A Common Stock

    2018-02-09$35.69/sh5,600$199,8640 total
  • Exercise/Conversion

    Class A Common Stock

    2018-02-12$11.83/sh+17,804$210,62117,804 total
  • Sale

    Class A Common Stock

    2018-02-12$35.61/sh17,804$634,0000 total
  • Sale

    Class A Common Stock

    2018-02-13$35.05/sh22,086$774,1140 total
  • Exercise/Conversion

    Class A Common Stock

    2018-02-13$11.83/sh+22,086$261,27722,086 total
  • Exercise/Conversion

    Option to purchase Common Stock

    2018-02-0914,18258,318 total
    Exercise: $11.83From: 2012-03-01Exp: 2019-02-28Class A Common Stock (14,182 underlying)
  • Exercise/Conversion

    Option to purchase Common Stock

    2018-02-1218,30440,014 total
    Exercise: $11.83From: 2012-03-01Exp: 2019-02-28Class A Common Stock (18,304 underlying)
  • Exercise/Conversion

    Option to purchase Common Stock

    2018-02-1322,08617,928 total
    Exercise: $11.83From: 2012-03-01Exp: 2019-02-28Class A Common Stock (22,086 underlying)
Footnotes (6)
  • [F1]The sales reported in the Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 4, 2017.
  • [F2]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $34.65 to $35.60, inclusive.
  • [F3]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $35.65 to $35.90, inclusive.
  • [F4]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $35.15 to $36.00, inclusive.
  • [F5]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $36.18 to $36.40, inclusive.
  • [F6]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $34.75 to $35.40, inclusive.

Issuer

PHIBRO ANIMAL HEALTH CORP

CIK 0001069899

Entity typeother

Related Parties

1
  • filerCIK 0001603584

Filing Metadata

Form type
4
Filed
Feb 12, 7:00 PM ET
Accepted
Feb 13, 9:14 PM ET
Size
26.5 KB